Successful therapy using high-dose furmonertinib for non-small cell lung cancer with leptomeningeal metastasis: a case report and literature review

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 1 news story.

本病例表明，伏美替尼是一种具有显著BBB穿透能力的第三代EGFR TKI，在控制LM和快速缓解颅内症状方面显示出前景。肺癌是全球第二常见的恶性肿瘤，也是死亡率最高的恶性肿瘤。在所有亚型中，肺腺癌最常见。软脑膜转移（LM）较为罕见，其特征是预后不良，不治疗的…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.